Cargando…
Recombinant Myxoma Virus-Derived Immune Modulator M-T7 Accelerates Cutaneous Wound Healing and Improves Tissue Remodeling
Complex dermal wounds represent major medical and financial burdens, especially in the context of comorbidities such as diabetes, infection and advanced age. New approaches to accelerate and improve, or “fine tune” the healing process, so as to improve the quality of cutaneous wound healing and mana...
Autores principales: | Yaron, Jordan R., Zhang, Liqiang, Guo, Qiuyun, Awo, Enkidia A., Burgin, Michelle, Schutz, Lauren N., Zhang, Nathan, Kilbourne, Jacquelyn, Daggett-Vondras, Juliane, Lowe, Kenneth M., Lucas, Alexandra R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7690590/ https://www.ncbi.nlm.nih.gov/pubmed/33105865 http://dx.doi.org/10.3390/pharmaceutics12111003 |
Ejemplares similares
-
Systemic Delivery of mLIGHT-Armed Myxoma Virus Is Therapeutic for Later-Stage Syngeneic Murine Lung Metastatic Osteosarcoma
por: Christie, John D., et al.
Publicado: (2022) -
Nuclear Export Inhibitor Selinexor Enhances Oncolytic Myxoma Virus Therapy against Cancer
por: Rahman, Masmudur M., et al.
Publicado: (2023) -
Virus-Derived Chemokine Modulating Protein Pre-Treatment Blocks Chemokine–Glycosaminoglycan Interactions and Significantly Reduces Transplant Immune Damage
por: Zanetti, Isabela R., et al.
Publicado: (2022) -
Local Serpin Treatment via Chitosan-Collagen Hydrogel after Spinal Cord Injury Reduces Tissue Damage and Improves Neurologic Function
por: Kwiecien, Jacek M., et al.
Publicado: (2020) -
Autologous Transplantation Using Donor Leukocytes Loaded Ex Vivo with Oncolytic Myxoma Virus Can Eliminate Residual Multiple Myeloma
por: Villa, Nancy.Y., et al.
Publicado: (2020)